Basal cell carcinoma treatment

We found 80 clinics & 33 doctors for Basal cell carcinoma Worldwide. AiroMedical ranks among 444 hospitals based on qualification, experience, success rate, and awards.

Basal cell carcinoma is a malignant skin tumor caused by prolonged and intense exposure to ultraviolet radiation. The tumor usually occurs on the face, neck, and head. In addition, they appear very small and grow slowly over the years. Surgery is the treatment of choice for basalioma. Alternative options are radiation therapy, laser, and cryotherapy.

Skin cancer that grows from basal cells is called basalioma. It is the most common skin tumor. The disease often develops in people around 60, grows slowly, and rarely metastasizes.

The cause is, as a rule, prolonged intense ultraviolet radiation. Some factors increase the risk of developing skin basalioma:

  • Decreased immunity (usually with HIV infection or after an organ transplant);
  • Chronic damage and inflammation of the skin;
  • People with fair skin;
  • Genetic predisposition.

A typical sign of basal cell carcinoma is a skin change in the form of a little, inconspicuous nodule. This nodule is skin-colored, and the change is barely noticeable. Therefore, the disease is also called white skin cancer.

Basalioma occurs in about 80% of cases on the face (most often on the nose). However, sometimes it can appear on the body and rarely on the palms and feet. Although the skin change does not cause discomfort for long, sometimes the area begins to itch or bleed.

Doctors examine skin changes under a special microscope; in some cases, a biopsy is required - the oncologist takes a piece of tissue from the nodule and examines it.

Depending on the size, dermatologists surgically remove part or all of the tumor. Operation (Mohs surgery) is the primary treatment for basal cell carcinoma. If an operation is not possible, there are alternative methods. These include laser, cryotherapy, and chemotherapy. However, surgery has a greater chance of success. Despite the malignancy, the prognosis for basal cell carcinoma is favorable. The success rate of treatment is over 95%.

Show more

7 countries and 51 cities for Basal cell carcinoma